New: Toujeo: beschikbaar in twee verschillende vormen
Minder pennen, minder voorraad en minder meenemen
Meer comfort
Eén enkele injectie kan de therapietrouw verbeteren1
Toujeo DoubleStar NL_V2
Toujeo® European Summary of Product Characteristics
Gerelateerde paginas
Taming Diabetes: A Daily Challenge for Martin and His Family
Follow 8-year-old Martin and his family as they navigate daily life with type 1 diabetes, from meal adaptations to school activities, showing resilience and optimism.
Living with T1D for 25 Years: Philippe's Inspiring Journey
At the dawn of his fifties, Philippe has tamed the diabetes he has lived with for over 25 years, along with his initial fear of injections. For him, this disease represents "a turning point, not an end." He leads a life "like everyone else," multiplying passions and fully enjoying every moment.
Need to identify risk of developing autoimmune type 1 diabetes? Test for autoantibodies!
Anti-islet autoantibodies that target proteins associated with beta-cells serve as biomarkers of autoimmune type 1 diabetes (T1D) development.1 The number of detectable autoantibodies through screening correlates with risk of developing autoimmune T1D.2 Assays for detecting autoimmune T1D have shown high sensitivity and specificity.3,4
Sanofi biedt u exclusieve content over onze verschillende therapeutische gebieden op één portal
speciaal voor professionals in de gezondheidszorg, inclusief wetenschappelijk nieuws, een ljst met
evenementen en tools en diensten voor uw dagelijkse praktik.